U2Bio Co., Ltd. (KOSDAQ:221800)
5,060.00
-190.00 (-3.62%)
At close: Nov 17, 2025
-3.62% (1Y)
| Market Cap | 72.35B |
| Revenue (ttm) | 25.15B |
| Net Income (ttm) | -2.69B |
| Shares Out | 11.29M |
| EPS (ttm) | -236.93 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 47,532,710 |
| Average Volume | 4,161,023 |
| Open | 4,820.00 |
| Previous Close | 5,250.00 |
| Day's Range | 4,650.00 - 5,660.00 |
| 52-Week Range | 2,370.00 - 6,460.00 |
| Beta | -0.06 |
| RSI | 67.94 |
| Earnings Date | n/a |